| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | C5A1-01-8825 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A1-02-8826 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A2-01-8827 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A2-02-8828 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A3-01-8830 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A3-02-8831 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A4-01-8832 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A4-02-8833 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A5-01-8834 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C5A5-02-8835 | Sample source:Blood Serum | Group:Negative Control | AU |
| Reversed phase POSITIVE ION MODE | C3A1-01-8810 | Sample source:Blood Serum | Group:Nonresponders | AU |
| Reversed phase POSITIVE ION MODE | C3A1-02-8811 | Sample source:Blood Serum | Group:Nonresponders | AU |
| Reversed phase POSITIVE ION MODE | C3A3-01-8815 | Sample source:Blood Serum | Group:Nonresponders | AU |
| Reversed phase POSITIVE ION MODE | C3A3-02-8816 | Sample source:Blood Serum | Group:Nonresponders | AU |
| Reversed phase POSITIVE ION MODE | C4A1-01-8819 | Sample source:Blood Serum | Group:Nonresponders | AU |
| Reversed phase POSITIVE ION MODE | C4A2-02-8822 | Sample source:Blood Serum | Group:Nonresponders | AU |
| Reversed phase POSITIVE ION MODE | C6A1-01-8836 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A1-02-8837 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A2-01-8838 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A2-02-8839 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A3-01-8840 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A3-02-8841 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A4-01-8842 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A4-02-8843 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A5-01-8844 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C6A5-02-8845 | Sample source:Blood Serum | Group:Positive Control | AU |
| Reversed phase POSITIVE ION MODE | C3A2-01-8812 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C3A2-02-8813 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C3A4-01-8817 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C3A4-02-8818 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C4A1-02-8820 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C4A2-01-8821 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C4A3-01-8823 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C4A3-02-8824 | Sample source:Blood Serum | Group:Responders | AU |
| Reversed phase POSITIVE ION MODE | C1A1-01-8800 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C1A1-02-8801 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C1A2-01-8802 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C1A2-02-8803 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C1A3-01-8804 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C1A3-02-8805 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C2A1-01-8806 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C2A1-02-8807 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C2A2-01-8808 | Sample source:Blood Serum | Group:Vehicle Control | AU |
| Reversed phase POSITIVE ION MODE | C2A2-02-8809 | Sample source:Blood Serum | Group:Vehicle Control | AU |
Return to study ST003201 main page
Download data matrix(Molecular signatures of xenograft colon cancer models treated with topotecan: A Mass Spectrometry-Based Study Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|